Share This Page Facebook Twitter Linked-In Tags: Health Care Prescription Drugs Manufacturing Pharmaceuticals Competition Merger Horizontal generic drugs market power Bureau of Competition Commissioners Date: October 30, 2020 Matter Number: 191 0182 By: Christine S. Wilson, Commissioner Statement of Commissioner Christine S. Wilson in the Matter of Pfizer Inc./Mylan N.V. (39.81 KB)